~Record Annual Revenues Exceeding $520M ~

~ Record Annual EPS of $1.39 Grows 60% ~

~ Record Q4 Revenue of $152M Grows 26% ~

~ Record Q4 EPS of $0.52 Grows 58% ~



ZOLL Medical Corporation (Nasdaq: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced that fiscal 2011 revenues were $523.7 million, compared to fiscal 2010 revenues of $444.0 million, an increase of 18%. Revenue results reflected a positive foreign exchange impact of approximately $6 million. Net income for the year grew 65% to $31.3 million, compared to $18.9 million in the prior year. Gross margins improved to 57% on the year, compared to 54% in the prior year. Diluted earnings per share grew 60% to $1.39, compared to $0.87 in the prior year. Backlog at the end of the year was approximately $30 million, as compared to $14 million at the end of the prior fiscal year. The Company ended the year with approximately $75 million in cash and short-term investments and generated approximately $45 million in cash from operations during the year.

Annual sales to the North American market increased 6% to $273.3 million, compared to $258.5 million for the prior year. Sales to the North American hospital market increased 14% to $142.6 million, compared to $125.1 million last year. Excluding U.S. Military sales, North American hospital sales increased 8% to $110.7 million from $102.4 million. U.S. Military sales were $32.0 million, compared to $22.7 million in the prior year period. Sales to the North American pre-hospital market decreased 2% to $130.7 million, compared to $133.4 million in the prior year. International revenues increased 21% to $139.3 million, compared to $114.8 million last year. Total Temperature Management revenue grew 38% to $26.0 million, compared to $18.9 million in the prior year. Total LifeVest revenues (which are excluded from geographic sales figures) increased 57% to $111.0 million compared to $70.7 million last year. Total AutoPulse sales decreased 1% to $17.3 million for the year, compared to $17.5 million in the prior year.

Read full article at : http://doubleinstocks.com/?p=19483


THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings, Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).